Related Experiment Videos
Insights
Managing cardiovascular diseases in older adults with multiple health conditions is complex due to polypharmacy and lack of tailored dosing guidelines. Current recommendations often exclude this vulnerable population.
Area of Science:
- Gerontology
- Cardiology
- Pharmacology
Background:
- Cardiovascular diseases (CVDs) like hypertension and heart failure are prevalent in aging populations.
- Older patients frequently have comorbidities (diabetes, renal dysfunction) requiring polypharmacy.
- Existing treatment guidelines often lack data for multimorbid elderly patients.
Abstract:
Cardiovascular diseases, such as arterial hypertension, heart failure, coronary artery disease, peripheral circulatory problems and atrial fibrillation are increasingly present in aged patients. Comorbidities, mainly diabetes, renal dysfunction, chronic bronchitis and degenerative joint diseases, are also frequent and need additional drug treatment. The usual polypharmacy often causes side effects due to overdosage and/or drug interactions. The main difficulty in choosing the proper therapeutic regimen consists in the lack of suitable dosing guidelines with adapted therapeutic targets for the older multimorbid population, usually not represented in the large controlled trials forming the basis of general recommendations. European guidelines for hypertension and heart failure are discussed as examples.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion